EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts
Year: 2008
Type: article
Source: Cancer Letters
Authors: J. Robert Newman, Emily E. Helman, Seena Safavy, Wenyue Zhang, Eben L. Rosenthal
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2009982090
